UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Eisai’s Aricept dominates dementia treatment market
by So Jae-hyeon
2018-06-29 15:24
Botulinum toxin makers compete to expand indications
by So Jae-hyeon
2018-06-29 14:07
GC, SK Chemical vaccines win export deals
by So Jae-hyeon
2018-06-25 12:13
Why was Il-yang out from innovative pharmaceutical firms list?
by So Jae-hyeon
2018-06-20 17:13
Companies enter pharma biz through equity investment, acquisition
by So Jae-hyeon
2018-06-18 16:13
라인
Samsung Bioepis to promote rheumatism treatments in Europe
by So Jae-hyeon
2018-06-14 14:59
What if South Korea supplies vaccines for North?
by So Jae-hyeon
2018-06-12 15:36
Obesity drugs marked poor sales in Q1
by So Jae-hyeon
2018-06-12 15:32
60 general hospitals use genetic therapy Invossa
by So Jae-hyeon
2018-06-11 15:12
Multinationals dominated drug sales in Q1 -- again
by So Jae-hyeon
2018-06-08 16:22
라인
Viagra, Cialis overcome by generic copies
by So Jae-hyeon
2018-06-05 10:55
US law expected to benefit Korean drugmakers
by So Jae-hyeon
2018-06-04 16:02
Eisai picks Chong Kun Dang as dementia drug sales partner
by So Jae-hyeon
2018-06-04 14:10
Biosimilars quickly catch up with originals in Korea
by So Jae-hyeon
2018-06-01 15:37
Pfizer Korea ignores reporters’ questions
by So Jae-hyeon
2018-06-01 15:18
라인
Korea United Pharm wages war on Chinese fake capsules
by So Jae-hyeon
2018-06-01 12:05
OCI enters pharma sector via joint venture with Bukwang
by So Jae-hyeon
2018-05-31 15:38
Procedures of genetic therapy Invossa exceed 1,000 cases
by So Jae-hyeon
2018-05-31 14:14
Korean biosimilar makers tap into Japan
by So Jae-hyeon
2018-05-30 15:41
Will biotech stocks rebound on listings in H2?
by So Jae-hyeon
2018-05-30 11:33
-
1
2
3
4
5
6
7
8
9
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top